Stock Scorecard



Stock Summary for 2seventy bio Inc (TSVT) - $5.64 as of 3/4/2024 3:14:25 PM EST

Total Score

13 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TSVT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TSVT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TSVT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TSVT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TSVT

Should You Buy 2seventy bio ( TSVT ) Ahead of Earnings? 3/4/2024 1:56:00 PM
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo 3/4/2024 7:00:00 AM
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo 3/4/2024 7:00:00 AM
The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO 2/9/2024 8:40:00 AM
Biotech Stock Roundup: GILD, AMGN & BMY's Q4 Results, MOR Up on NVS Deal & More 2/8/2024 3:56:00 PM
Bristol Myers ( BMY ) , TSVT CAR T-Cell Therapy to Face FDA's ODAC 2/6/2024 4:03:00 PM
Why Is Regeneron Pharmaceuticals Stock Trading Higher Today? - Regeneron Pharmaceuticals ( NASDAQ:REGN ) 2/2/2024 4:08:00 PM
Bristol Myers Squibb results top expectations as newer drugs help fuel growth 2/2/2024 12:01:00 PM
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results 2/2/2024 11:30:00 AM
Biotech Stock Roundup: GSK's Q4 Results, VRTX Gains on Update, TSVT Up on REGN Deal 2/1/2024 2:45:00 PM

Financial Details for TSVT

Company Overview

Ticker TSVT
Company Name 2seventy bio Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2023
Next Earnings Date 3/11/2024

Stock Price History

Last Day Price 5.64
Last Day Price Updated 3/4/2024 3:14:25 PM EST
Last Day Volume 666,048
Average Daily Volume 1,484,330
52-Week High 12.69
52-Week Low 1.53
Last Price to 52 Week Low 268.63%

Valuation Measures

Trailing PE N/A
Industry PE 70.65
Sector PE 52.69
5-Year Average PE -1.35
Free Cash Flow Ratio 3.17
Industry Free Cash Flow Ratio 12.51
Sector Free Cash Flow Ratio 30.52
Current Ratio Most Recent Quarter 4.08
Total Cash Per Share 1.78
Book Value Per Share Most Recent Quarter 6.05
Price to Book Ratio 0.93
Industry Price to Book Ratio 6.12
Sector Price to Book Ratio 21.51
Price to Sales Ratio Twelve Trailing Months 1.96
Industry Price to Sales Ratio Twelve Trailing Months 12.87
Sector Price to Sales Ratio Twelve Trailing Months 7.74

Share Statistics

Total Shares Outstanding 50,625,000
Market Capitalization 285,525,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 13.01%
Reported EPS 12 Trailing Months -3.77
Reported EPS Past Year -2.91
Reported EPS Prior Year -7.58
Net Income Twelve Trailing Months -183,938,000
Net Income Past Year -254,200,000
Net Income Prior Year -292,213,000
Quarterly Revenue Growth YOY -10.20%
5-Year Revenue Growth 67.81%

Balance Sheet

Total Cash Most Recent Quarter 90,226,000
Total Cash Past Year 266,270,000
Total Cash Prior Year 265,057,000
Net Cash Position Most Recent Quarter 90,226,000
Net Cash Position Past Year 266,270,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 310,466,000
Total Stockholder Equity Prior Year 359,822,000
Total Stockholder Equity Most Recent Quarter 306,422,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.37
MACD Signal 0.45
20-Day Bollinger Lower Band 1.02
20-Day Bollinger Middle Band 3.66
20-Day Bollinger Upper Band 6.30
Beta 1.88
RSI 55.83
50-Day SMA 6.55
200-Day SMA 0.00

System

Modified 3/2/2024 4:10:38 PM EST